Summary & Overview
CPT 80424: Fractionated Plasma Catecholamines, Paired Sampling
CPT code 80424 describes a laboratory procedure that measures fractionated catecholamine levels in two plasma samples collected at different times during a single session, typically before and after a pharmacologic challenge. This paired-sample testing can be clinically important for diagnosing or monitoring conditions that affect catecholamine secretion and for confirming biochemical response to stimuli. Nationally, accurate coding for stimulated catecholamine testing affects laboratory workflow, medical necessity determinations, and claim adjudication for complex endocrine and cardiovascular evaluations.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for CPT code 80424, typical sites of service, and the laboratory service type. The publication provides benchmarks and coding considerations relevant to payers and providers, highlights typical billing modifiers and claim components (Data not available in the input for payer-specific rates), and outlines how the test is positioned within diagnostic pathways involving pharmacologic challenge testing.
This summary is intended for a national audience of billing managers, laboratory directors, and policy analysts seeking a practical briefing on the clinical purpose and billing characterization of CPT code 80424.
Billing Code Overview
CPT code 80424 measures fractionated catecholamines in plasma from two separate blood samples taken at different times during a single procedure. The test quantifies hormone levels before and after a pharmacologic challenge (for example, a stimulant such as captopril) to assess biochemical response patterns.
Service type: Laboratory diagnostic blood test with stimulated challenge and paired sampling.
Typical site of service: Hospital outpatient laboratory or clinical laboratory setting, often performed in facilities that can administer and monitor a pharmacologic challenge and collect timed blood specimens.
Clinical & Coding Specifications
Clinical Context
A patient with episodic or sustained hypertension and symptoms suggestive of catecholamine excess (headache, palpitations, diaphoresis) is referred for biochemical evaluation of suspected pheochromocytoma or paraganglioma. The typical workflow: an outpatient or inpatient clinician orders fractionated plasma catecholamines measured pre- and post-challenge (for example, with captopril or another stimulant) to assess changes in catecholamine levels. The patient presents to the laboratory or phlebotomy unit after appropriate medication and dietary preparation is confirmed. Two timed blood plasma samples are collected during the procedure: one baseline specimen and a second specimen after the challenge at the specified interval. Samples are transported to the laboratory, processed, and analyzed by the laboratory analyst for fractionated catecholamines (epinephrine, norepinephrine, dopamine and/or their metabolites depending on lab protocol). Results are reported to the ordering provider, who integrates biochemical findings with imaging (if performed) and clinical presentation to guide further management, such as biochemical confirmation, localization studies, or referral to endocrinology or surgery.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing only the professional interpretation component separate from the facility or technical component |